Cardiomyopathy and heart failure in diabetes (Q34451742)

2 August 2017

1 reference

title

Cardiomyopathy and heart failure in diabetes (English)

1 reference

2 August 2017

1 reference

1 reference

Tang WH

1

1 reference

2 August 2017

Young JB

series ordinal

2

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Endocrinology and Metabolism Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

1031-1046

1 reference

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Preclinical abnormality of left ventricular function in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Incidence of heart failure in 2,737 older persons with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetes as a risk factor for sudden death

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The clinical implications of diabetic heart disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

National trends in the initial hospitalization for heart failure

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Non invasive evaluation of left ventricular performance in 294 diabetic patients without clinical heart disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The pathophysiology of myocardial ischaemia

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Impact of diabetes on cardiac structure and function: the strong heart study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

1 reference

7 January 2021

Myocardial alterations in diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Significant weight gain with rezulin therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetes and decline in heart disease mortality in US adults.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The myocardial and vascular pathology of diabetic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Pulmonary edema associated with troglitazone therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Troglitazone-induced pulmonary edema

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Glycemic control and heart failure among adult patients with diabetes

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Role of diabetes in congestive heart failure: the Framingham study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Mortality among diabetics in a national sample

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetic angiopathy: a specific vascular disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction: a 15-year follow-up study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Clinically unrecognized ventricular dysfunction in young diabetic patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Left ventricular systolic function in middle-aged patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Ten-year trends in hospital care for congestive heart failure: improved outcomes and increased use of resources

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The UGDP Controversy: Clinical Trials Versus Clinical Impressions

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Evidence for cardiomyopathy in familial diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

New type of cardiomyopathy associated with diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Noninvasive Estimation of Myocardial Performance in Patients with Diabetes: Effect of Alcohol Administration

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Echocardiographic features of impaired ventricular function in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Insulin resistance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Pulmonary edema associated with rosiglitazone and troglitazone

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Diabetic heart disease: clinical considerations

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

Reduced Myocardial Flow Reserve in Non–Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70226-7

7 January 2021

10.1016/S0889-8529(05)70226-7

Identifiers

DOI

1 reference

2 August 2017

1 reference